Download a full copy of the Livongo Q2 Earnings Report here. Mountain View, CA – September 5, 2019 – Livongo Health, Inc. (NASDAQ: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter ended June 30, 2019.“Our impressive second…Read more
Join the webcast here. Tuesday, September 10, 2019 12:20 EST/9:20 PST Mountain View, CA – August 27, 2019 – Livongo Health, Inc. (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the Company will be participating in the Morgan Stanley 17th Annual Healthcare…Read more
• Tullman recognized for transforming the healthcare experience for people living with chronic conditions • Fellow 2019 Laureates include Speaker of the House of Representatives Nancy Pelosi, J.K. Rowling, and Wendy Abrams Mountain View, CA – August 20, 2019 – Today, Livongo announced that Founder and Executive Chairman Glen Tullman will be honored with a…Read more
MOUNTAIN VIEW, Calif. — August 7, 2019 —Livongo Health, Inc., (Nasdaq: LVGO) today announced it will hold a conference call on Thursday, September 5, 2019 at 8:00 a.m. Eastern time to discuss results for the second quarter ended June 30, 2019. Financial results will be issued in a press release prior to the call. Livongo…Read more
MOUNTAIN VIEW, Calif., July 29, 2019 (GLOBE NEWSWIRE) — Livongo Health, Inc., (Nasdaq: LVGO) today announced the closing of its initial public offering of 14,590,050 shares of its common stock at a price of $28.00 per share, which includes the full exercise of the underwriters’ option to purchase 1,903,050 additional shares of common stock to…Read more
MOUNTAIN VIEW, Calif., July 24, 2019 (GLOBE NEWSWIRE) — Livongo Health, Inc. (Livongo) today announced the pricing of its initial public offering of 12,687,000 shares of its common stock at a price of $28.00 per share for total gross proceeds of approximately $355.2 million. In addition, Livongo has granted the underwriters a 30-day option to…Read more
Mountain View, CA – June 26, 2019 – Livongo, a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the launch of a bi-directional integration with the top smartwatches in the market, including leading models from Apple, Fitbit, and Samsung. Livongo Members can now connect their…Read more
Mountain View, CA – June 10, 2019– Livongo, the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of a study conducted in collaboration with Eli Lilly and Company. The study demonstrated 94 percent of Livongo for Diabetes program Members who completed a program…Read more
Mountain View, CA – June 4, 2019 – Livongo, the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has appointed Karen L. Daniel, former Executive Director, Division President, and Chief Financial Officer of Black & Veatch Corporation, to its Board of Directors and…Read more
Mountain View, CA – May 14, 2019 – Livongo, the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has appointed Sandra L. Fenwick, Chief Executive Officer of Boston Children’s Hospital, to its Board of Directors. Since being named Chief Executive Officer of Boston…Read more